Search
Find Drugs
Advanced Search

 


Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data

Piqray
Generic Name : Alpelisib
Indication : In combination w/ fulvestrant for the treatment of postmenopausal women & men w/ hormone receptor (HR) +ve, human epidermal growth factor receptor 2 (HER2) -ve, advanced or metastatic breast cance...
Manufacturer : Novartis
Distributor : Zuellig

Pluvicto
Generic Name : Lutetium (177Lu) vipivotide tetraxetan
Indication : In combination w/ androgen deprivation therapy w/ or w/o androgen receptor (AR) pathway inhibition for the treatment of progressive prostate-specific membrane antigen (PSMA) +ve metastatic castration-...
Manufacturer : Novartis

pms-Erlotinib
Generic Name : Erlotinib
Indication : Advanced stage of non-small cell lung cancer (NSCLC) where chemotherapy has not helped to stop disease progression; the disease has not worsened after 4 cycles of 1st line chemotherapy; or activating ...
Manufacturer : Pharmascience
Distributor : T-BOMA

Polivy
Generic Name : Polatuzumab vedotin
Indication : In combination w/ rituximab, cyclophosphamide, doxorubicin, & prednisone (R-CHP) for the treatment of previously untreated diffuse large B-cell lymphoma (DLBCL) in adult patients. In combination w...
Manufacturer : Roche
Distributor : DKSH

Retsevmo
Generic Name : Selpercatinib
Indication : Monotherapy for adults w/ advanced RET fusion +ve NSCLC not previously treated w/ RET inhibitor; advanced RET fusion +ve thyroid cancer who require systemic therapy following prior treatment w/ sorafe...
Manufacturer : Eli Lilly
Distributor : Zuellig

Rixathon
Generic Name : Rituximab
Indication : Treatment of previously untreated patients w/ stage III-IV follicular lymphoma in combination w/ chemotherapy. Maintenance therapy for the treatment of follicular lymphoma patients responding to induc...
Manufacturer : Sandoz
Distributor : Zuellig

Rozlytrek

Rybrevant
Generic Name : Amivantamab
Indication : Monotherapy for treatment of adult patients w/ advanced NSCLC w/ activating epidermal growth factor receptor (EGFR) Exon 20 insertion mutations, after failure of platinum-based therapy.
Manufacturer : Janssen

Rydapt
Generic Name : Midostaurin
Indication : In combination w/ standard daunorubicin & cytarabine induction & high-dose cytarabine consolidation chemotherapy, & for patients in complete response followed by Rydapt single agent mainte...
Manufacturer : Novartis
Distributor : DKSH / Four Star

Scemblix
NEW
Generic Name : asciminib
Indication : Philadelphia chromosome +ve chronic myeloid leukaemia in chronic phase (Ph+ CML-CP) in adults previously treated w/ ≥2 tyrosine kinase inhibitors.
Manufacturer : Novartis
Distributor : Zuellig

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in